Published in Theor Appl Genet on June 01, 1996
A gradual process of recombination restriction in the evolutionary history of the sex chromosomes in dioecious plants. PLoS Biol (2004) 2.20
Extreme population structure and high interspecific divergence of the Silene Y chromosome. Genetics (2005) 0.96
Molecular and quantitative genetic differentiation in European populations of Silene latifolia (Caryophyllaceae). Ann Bot (2007) 0.92
Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry (1996) 1.89
Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry (1975) 1.17
Catecholamine metabolism, depressive illness, and drug response. Arch Gen Psychiatry (1972) 1.14
Distinct regional and subcellular localization of adenylyl cyclases type 1 and 8 in mouse brain. Neuroscience (2007) 1.08
Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey Macaca arctoides. Brain Res (1976) 1.00
Adenosine triphosphate--metal--norepinephrine ternary complexes and catecholamine binding. Nature (1965) 0.96
Evolution and recombination of bovine DNA repeats. J Mol Evol (1995) 0.93
The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med (1987) 0.93
Diverse spore rains and limited local exchange shape fern genetic diversity in a recently created habitat colonized by long-distance dispersal. Ann Bot (2012) 0.93
Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry (1979) 0.92
Co-ordination chemistry and membrane function with particular reference to the synapse and catecholamine transport. Nature (1965) 0.90
Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry (1984) 0.89
Effects of fire ant venom alkaloids on platelet and neutrophil function. Life Sci (1993) 0.88
An improved procedure of 3-methoxy-4-hydroxyphenyl-ethylene glycol determination by gas-liquid chromatography. Anal Biochem (1970) 0.88
In vivo studies of the metabolism of norepinephrine in the central nervous system. J Pharmacol Exp Ther (1968) 0.87
Amplified fragment length polymorphism analysis of genetic diversity of Haemonchus contortus during selection for drug resistance. Int J Parasitol (2001) 0.87
The time course of noradrenergic pre- and postsynaptic activity during chronic desipramine treatment. Eur J Pharmacol (1980) 0.87
CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Arch Gen Psychiatry (1983) 0.86
Adrenocortical steroid hormones, electrolytes, and the disposition of the catecholamines with particular reference to depressive states. J Psychiatr Res (1972) 0.86
An exceptional case of tyrosinosis. J Ment Defic Res (1968) 0.85
Primary affective disorder, clinical state change, and MHPG excretion: a longitudinal study. Arch Gen Psychiatry (1978) 0.85
Increased ouabain binding after repeated noradrenergic stimulation. Brain Res (1981) 0.83
Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients. Neuropsychopharmacology (1994) 0.83
Mania. Diagnosis, state measurement and prediction of treatment response. J Affect Disord (1985) 0.83
Social behavior of monkeys selectively depleted of monoamines. Science (1971) 0.83
MHPG excretion by patients with affective disorders. Int Pharmacopsychiatry (1974) 0.83
A multi-vantaged approach to measurement of behavioral and affect states for clinical and psychobiological research. Psychol Rep (1984) 0.81
Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res (1986) 0.81
Brain catecholamine metabolites and behavior in morphine withdrawal. Eur J Pharmacol (1982) 0.81
Evidence against specificity of electrical stimulation of the nucleus locus coeruleus in activating the sympathetic nervous system in the rat. Brain Res (1980) 0.81
Genetic distances within and across cattle breeds as indicated by biallelic AFLP markers. Anim Genet (2002) 0.81
Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid. Clin Pharmacol Ther (1985) 0.81
A schizophreniform behavioral psychosis mediated by dopamine. Am J Psychiatry (1975) 0.81
Estimates of dopamine and serotonin synthesis by the awake human brain. J Neurochem (1980) 0.80
Purification of an UDP-glucose:flavone, 7-O-glucosyltransferase, from Silene latifolia using a specific interaction between the enzyme and phenyl-Sepharose. FEBS Lett (1993) 0.80
CSF monoamine metabolites in mania. Am J Psychiatry (1983) 0.80
Catecholamine metabolite excretion following intraventricular injection of 6-OH-dopamine. Brain Res (1972) 0.80
Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry (1994) 0.79
Calcium function in affective disorders and healthy controls. Biol Psychiatry (1988) 0.79
Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res (1989) 0.79
The metabolism of circulating norepinephrine by human subjects. J Pharmacol Exp Ther (1971) 0.79
3-Methoxy-4-hydroxy phenylglycol (MHPG) excretion in depressive states. A pilot study. Arch Gen Psychiatry (1968) 0.79
In vivo location and destruction of the locus coeruleus in the stumptail macaque (Macaca arctoides). Brain Res (1975) 0.79
Catecholamine metabolism and disposition in healthy and depressed subjects. Arch Gen Psychiatry (1987) 0.79
3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo. Science (1979) 0.78
Acute effects of neuroleptics on unmedicated schizophrenic patients and controls. Biol Psychiatry (1993) 0.78
Transfer RNA and the regulation of protein synthesis in rat cerebral cortex during neural development. J Neurochem (1974) 0.78
Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Arch Gen Psychiatry (1987) 0.78
Effects of chronic dietary lithium on activity and regulation of (Na+,K+)-adenosine triphosphatase in rat brain. Biochem Pharmacol (1980) 0.78
Biochemistry and suicidal behavior in depressed patients. Biol Psychiatry (1986) 0.78
Dihydroxyphenylacetic acid conjugate: natural occurrence and demonstration of probenecid-induced accumulation in rat striatum, olfactory tubercles and frontal cortex. Eur J Pharmacol (1977) 0.78
Brain (Na+, K+)-ATPase and noradrenergic activity: effects of hyperinnervation and denervation on high-affinity ouabain binding. J Neurochem (1982) 0.78
Urinary catecholamine metabolites during behavioral changes in a patient with manic-depressive cycles. Science (1973) 0.78
Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment. Arch Gen Psychiatry (1981) 0.78
Regional distribution of dopamine metabolites in human and primate brain. Commun Psychopharmacol (1978) 0.78
Stimulation of the dorsal noradrenergic dundle and field potentials in the locus coeruleus. Brain Res (1976) 0.78
The occurrence of free vs. conjugated MHPG in non-human and human primate brain. Psychopharmacol Commun (1976) 0.77
A direct method for studying 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) production by brain in awake animals. Eur J Pharmacol (1977) 0.77
Depressive mania versus agitated depression: biogenic amine and hypothalamic-pituitary-adrenocortical function. Biol Psychiatry (1994) 0.77
Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants. Arch Gen Psychiatry (1972) 0.77
Diagnoses, catecholamine metabolism, and plasma dopamine-beta-hydroxylase. J Am Acad Child Adolesc Psychiatry (1988) 0.77
Catecholamine metabolism, depression and stress. Nature (1971) 0.77
Hydrocortisone-mediated increase of norepinephrine uptake by brain slices. Science (1971) 0.77
Plasma dopamine-beta-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys. Biol Psychiatry (1987) 0.77
Locus coeruleus stimulation increases noradrenergic metabolite levels in rat spinal cord. Brain Res (1979) 0.77
Blood-brain barrier to 6-hydroxydopamine: uptake by heart and brain. Life Sci (1975) 0.77
Plasma free MHPG and neuroendocrine responses to challenge doses of clonidine in Tourette's syndrome: preliminary report. Life Sci (1981) 0.77
A kinetic study of the disposition of circulating norepinephrine in normal male subjects. J Pharmacol Exp Ther (1970) 0.77
Stress, depression, and mania: relationship between perceived role of stressful events and clinical and biochemical characteristics. Acta Psychiatr Scand (1990) 0.77
Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects. Arch Gen Psychiatry (1986) 0.77
Mania: sympathoadrenal function and clinical state. Psychiatry Res (1991) 0.77
A kinetic model for the study of the disposition of circulating norepinephrine. J Pharmacol Exp Ther (1970) 0.77
Proceedings: Urinary MHPG excretion in primary affective disorders. Psychopharmacol Bull (1974) 0.77
A method for the preparation and separation of 3-methoxy-4-hydroxyphenethyleneglycol conjugates. Biochem Med (1975) 0.77
Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment. Psychol Med (1982) 0.76
Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin. Life Sci (1980) 0.76
[Subfertility in South Limburg: calculation of incidence and appeal for specialist care]. Ned Tijdschr Geneeskd (1995) 0.76
Cerebrospinal fluid, plasma, and urinary MHPG in children. Life Sci (1981) 0.76
Identification and properties of UDP-glucose: cyanidin-3-O-glucosyltransferase isolated from petals of the red campion (Silene dioica). Biochem Genet (1978) 0.76
Brain norepinephrine and behavior. A behavioral and kinetic study. Psychosom Med (1966) 0.76
Catecholamines and diagnoses in children. J Am Acad Child Adolesc Psychiatry (1990) 0.76
Biochemical evidence for simultaneous activation of multiple locus coeruleus efferents. Life Sci (1980) 0.76
Biogenic amine and metabolite levels in depressed patients with high versus normal hypothalamic-pituitary-adrenocortical activity. Am J Psychiatry (1987) 0.76
Decreased 24-hour urinary MHPG in childhood autism. Am J Psychiatry (1979) 0.76
Specificity of depressive diseases. Annu Rev Med (1978) 0.76
Differential effects of short and long term lithium on tryptophan uptake and serotonergic function in cat brain. Life Sci (1981) 0.76
Clinical and biochemical heterogeneity of depressive disorders. Ann Intern Med (1978) 0.75
Lithium effects on high-affinity tryptophan uptake: evidence against a stabilization mechanism. Brain Res (1980) 0.75
Effects of debrisoquin on CSF and plasma HVA concentrations in man. Life Sci (1985) 0.75
Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. Am J Psychiatry (1984) 0.75
Noradrenergic function and depression, too much or too little? Can J Neurol Sci (1980) 0.75
Noradrenergic stimulation in vivo increases (Na+, K+)-adenosine triphosphatase activity. Life Sci (1981) 0.75
Biological component of the NIMH clinical research branch collaborative program on the psychobiology of depression: I. Background and theoretical considerations. Psychol Med (1980) 0.75
Measurement of 3-methoxy-4-hydroxyphenylacetic acid (HVA) in plasma by high-performance liquid chromatography with electrochemical detector (HPLC-EC). Anal Biochem (1983) 0.75
Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) in man: preliminary report. Life Sci (1980) 0.75
Plasma free and conjugated MHPG in psychiatric patients. A pilot study. Arch Gen Psychiatry (1980) 0.75
Relationships between central nervous system noradrenergic function and plasma and urinary concentrations of norepinephrine metabolites. Adv Biochem Psychopharmacol (1984) 0.75
Variance in the production of homovanillic acid and 3-methoxy-4-hydroxyphenethyleneglycol by the awake primate brain. Life Sci (1980) 0.75
Pretreatment amine neurotransmitter system interrelationships in depression [proceedings]. Psychopharmacol Bull (1981) 0.75